Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas
    Journal Article

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Characteristics and outcomes of patients with metastatic KRAS-mutant lung adenocarcinomas: The Lung Cancer Mutation Consortium experience
    Journal Article

    El Osta, B.; Behera, M.; Kim, S.; Berry, L. D.; Sica, G.; Pillai, R. N.; Owonikoko, T. K.; Kris, M. G.; Johnson, B. E.; Kwiatkowski, D. J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements
    Journal Article

    Chang, J. C.; Zhang, L.; Drilon, A. E.; Chi, P.; Alaggio, R.; Borsu, L.; Benayed, R.; Travis, W. D.; Ladanyi, M.; Antonescu, C. R.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Neoantigen-directed immune escape in lung cancer evolution
    Journal Article

    Rosenthal, R.; Cadieux, E. L.; Salgado, R.; Al Bakir, M.; Moore, D. A.; Hiley, C. T.; Lund, T.; Tanić, M.; Reading, J. L.; Joshi, K.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
    Journal Article

    Leighl, N. B.; Hellmann, M. D.; Hui, R.; Carcereny, E.; Felip, E.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; more...
    The Lancet Respiratory Medicine (2019)

    Fulltext@MSK | Save
  • Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers
    Journal Article

    Vojnic, M.; Kubota, D.; Kurzatkowski, C.; Offin, M.; Suzawa, K.; Benayed, R.; Schoenfeld, A. J.; Plodkowski, A. J.; Poirier, J. T.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
    Editorial

    Ladanyi, M.; Sanchez Vega, F.; Zauderer, M.
    Genome Medicine (2019)

    Fulltext@MSK | Save
  • Exceptional responders with invasive mucinous adenocarcinomas: A phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
    Journal Article

    Drilon, A.; Schoenfeld, A. J.; Arbour, K. C.; Litvak, A.; Ni, A.; Montecalvo, J.; Yu, H. A.; Panora, E.; Ahn, L.; Kennedy, M.; more...
    Cold Spring Harbor Molecular Case Studies (2019)

    Fulltext@MSK | Save
  • A phase I/Ib trial of the VEGFR-sparing multikinase RET inhibitor RXDX-105
    Journal Article

    Drilon, A.; Fu, S.; Patel, M. R.; Fakih, M.; Wang, D.; Olszanski, A. J.; Morgensztern, D.; Liu, S. V.; Cho, B. C.; Bazhenova, L.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Origin and development of blood cells
    Book Section

    Chow, A.; Frenette, P. S.
    In Greer, J. P.; Rodgers, G. M.; Glader, B.; Arber, D. A.; Means, R. T. Jr; List, A. F.; Applebaum, F. R.; Dispenzieri, A.; Fehniger, T. A. (Eds.) Wintrobe's Clinical Hematology. 14th ed (2019)

    Fulltext@MSK | Save